Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
February 13, 2024 at 02:15 am EST
Share
Sakai Chemical Industry Co., Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the full year, the company expected net sales of ¥84,000 million, operating profit of ¥1,900 million, loss attributable to owners of parent of ¥7,000 million and loss per share of ¥432.01.
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
SAKAI CHEMICAL INDUSTRY CO., LTD. 
